✦ LIBER ✦

Second bone marrow transplantation for leukemic relapse without graft-vs.-host disease prophylaxis

✍ Scribed by Francois-Xavier Mahon; Gerald Marit; Florence Viard; Philippe Bernard; Josy Reiffers

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 251 KB
Volume: 43
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830430423

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Orthotopic liver transplantation for acu

Orthotopic liver transplantation for acute grade IV hepatic graft-versus-host disease following bone marrow transplantation

✍ Figuera, Angela; Tomás, José F.; Otero, Mariá J.; Moreno, Enrique; García, Ismae 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB 👁 2 views

A multivariate approach for assessing se

A multivariate approach for assessing severity of acute graft-versus-host disease in bone marrow transplantation

✍ Rudolph S. Parrish; Linda J. Hazlett; Kerry D. Bridges; P. Jean Henslee-Downey 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB 👁 2 views

Patients undergoing bone marrow transplantation are at high risk of developing acute graft-versus-host disease (GVHD) which is a primary limiting factor for this procedure inasmuch as it is responsible for high morbidity rates and is associated with poor survival outcome. To provide improved treatme

Intra-mesenteric artery steroid administ

Intra-mesenteric artery steroid administration relieved severe refractory gastro-intestinal graft-vs.-host disease in an allogeneic bone marrow transplantation patient

✍ Sato, Tsutomu; Sakamaki, Sumio; Nagaoka, Yasuhiro; Kuribayashi, Kageaki; Nagamac 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

We report a case of severe gastro-intestinal (G-I) graft-vs.-host disease (GVHD) successfully treated with intra-mesenteric artery steroid administration. A 29-year-old man with severe aplastic anemia (SAA) was submitted to HLA-identical unrelated allogeneic bone marrow transplantation (BMT) and was

Expression of CD134 (0X-40) on T cells d

Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease

✍ L.S. Lamb Jr; S.A. Abhyankar; L. Hazlett; W. O'Neal; R.S. Folk; S. Vogt; R.S. Pa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

## CD134 (OX-40 ) is an activation-associated antigen which functions as a costimulatory receptor for CD4؉ T cells. In order to determine the expression of CD134 during immune recovery following allogeneic bone marrow transplantation (BMT), we measured its expression on T cells and T cell subsets